Hypercoagulable States - 12/11/11
Doi : 10.1016/j.ccc.2011.09.007
Julia A.M. Anderson, MD a, b, Jeffrey I. Weitz, MD c, ⁎ 
a Department of Clinical and Laboratory Hematology, Royal Infirmary of Edinburgh, Scotland EH16 4SA, UK
b Department of Medicine, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
c Departments of Medicine, Biochemistry and Biomedical Sciences, Thrombosis & Atherosclerosis Research Institute, McMaster University, 237 Barton Street East, Hamilton, ON L8L 2X2, Canada
Corresponding authorKeywords : Thrombophilia, Hypercoagulable state, Thrombosis, Thromboprophylaxis, Anticoagulation
Mappa
| A version of this article originally appeared in Clinics in Chest Medicine, 31:4. |
© 2011
Elsevier Inc. Tutti i diritti riservati.
Vol 27 - N° 4
P. 933-952 - ottobre 2011 Ritorno al numero
Articolo precedente
- Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism
- Paul D. Stein, Fadi Matta
- Mortality Risk Assessment and the Role of Thrombolysis in Pulmonary Embolism
- Mareike Lankeit, Stavros Konstantinides
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?